|
BIOLOGICAL RESEARCH
|
|
|
|
|
|
Ryazantseva U.V., Boiko A.S., Levchuk L.A., Simutkin G.G., Ivanova S.A., Vasilieva S.N., Roshchina O.V., Bokhan N.A.(Tomsk) Relationship between platelet-derived growth factors and clinical and clinical-dynamic characteristics in patients with mood disorders……………………………………………………….
Boksha I.S., Savushkina O.K., Prokhorova T.A., Tereshkina E.B., Vorobyova E.A., Piskarev M.V., Burbaeva G.Sh.(Moscow) Forms of periodic catatonia in schizophrenia spectrum disorders: differences in the levels of platelet enzyme activity ……………………………………………………………………….…..
|
5
13
|
|
|
|
|
CLINICAL PSYCHIATRY
|
|
|
|
|
|
Petkun D.A., Tiguntsev V.V., Agarkov A.A., Mazur M.N., Gorbatsevich Yu.N., Maltseva Yu.L., Pogorelova T.V.(Tomsk) Effectiveness of cognitive remediation in the treatment of schizophrenia (clinical case) …………………………………………………………………………………………………………….
Zarubina N.V.(Yaroslavl) Prevalence of depressive disorders in patients with multiple sclerosis with foci of demyelination ………………………………………………………………………………………………...
Vasilieva S.N., Simutkin G.G., Schastnyy E.D., Lebedeva E.V., Surovtseva A.K., Smirnova N.S., Didenko E.V.(Tomsk) Patient adherence to drug therapy for bipolar affective disorder …………………….
|
24
32
41
|
|
|
|
|
LECTURES. REVIEWS
|
|
|
|
|
|
Leurda E.V., Makushkina O.A., Frolova A.V. (Moscow) Features of behavior regulation in persons with severe mental disorders comorbid with addiction to psychoactive substances ……………………………….
Munin A.O., Golubev S.A.(Moscow) Definition of suicide risk in patients with schizophrenia (literature review) …………………………………………………………………………………………………………..
|
49
65
|
|
|
|
|
PSYCHOTHERAPY
|
|
|
|
|
|
Skutin A.V., Gromov V.A., Shaikhetdinov R.G., Moroz I.N.(Chelyabinsk) Efficiency and comparative results of using psychotechnological methods of psychocorrection ‒ gaudiumotherapy and gelototherapy…
|
75
|
|
|
|
|
SUICIDOLOGY
|
|
|
|
|
|
Golenkov A.V., Zotov P.B., Aleksandrova D.O., Sultanov O.V.(Cheboksary, Tyumen) Suicides among Russians at the age of reverse development………………………………………………………………………….
|
86
|
|
|
|
|
PSYCHOPHARMACOTHERAPY
|
|
|
|
|
|
Balakireva E.E., Nikitina S.G., Kulikov A.V., Shushpanova O.V., Koval-Zaitsev A.A., Ivanov M.V.,
Blinova T.E., Shalina N.S.(Moscow) Clinical experience with the use of low doses of chlorpromazine for the treatment of catatonic agitation in children with autism spectrum disorders …………………………………….
|
92
|
|
|
|
|
OBITUARY
|
|
|
In memory of Stanislav Markovich Umansky ………………………………………………………………………….
|
101
|
|
|
|
|
|
|
